Stay updated on CABozantinib in NSCLC MET Clinical Trial
Sign up to get notified when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.

Latest updates to the CABozantinib in NSCLC MET Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew guidance sections were added to the study record (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was standardized. Older labels such as Verified and Last known status was: were removed or updated to Revision: v3.6.0, with new fields Last verified and Last known status was added.SummaryDifference1%

- Check21 days agoChange DetectedA new Revision: v3.5.5 was added and the previous Revision: v3.5.4 was removed, indicating a minor update to the page's revision history rather than changes to the study content.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision stamp updated from v3.5.3 to v3.5.4, indicating a newer page version is now live. This reflects a minor update to the page rather than a substantive change to study details.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page shows a new Revision: v3.5.3 label, replacing the previous v3.5.2. This reflects a minor platform update and does not alter the study data or its presentation.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 was removed. This maintenance update does not modify study content.SummaryDifference0.0%

- Check78 days agoChange DetectedPadova, PD, Italy 35128 has been added and Padua, PD, Italy 35128 removed from the locations list.SummaryDifference0.0%

Stay in the know with updates to CABozantinib in NSCLC MET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.